New insights into genetic aspects of alzheimer's disease: Does genetic information make a difference in clinical practice?

Postgraduate Medicine

Volumn 108, Issue 5, 2000, Pages 119-129

  Blacker, Deborah ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN;

EID: 0033755122     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.10.1267     Document Type: Article

References (20)

1. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
2. The gene defects responsible for familial Alzheimer's disease
3. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
4. Cloning of a gene bearing missense mutation in early-onset familial Alzheimer's disease
5. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
6. Familial Alzheimer's disease in kindreds with missense mutation in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
7. The genetics of Alzheimer's disease: Current status and future prospects
8. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease
9. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
10. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
11. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: The Cache County Study
12. Apolipoprotein E and cognitive change in an elderly population
13. APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease
14. The clinical introduction of genetic testing for Alzheimer disease: An ethical perspective
15. Genetic testing and Alzheimer disease. Has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics and Society
16. Consensus report of the Working Group on 'Molecular and Biochemical Markers of Alzheimer's Disease.' The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute of Aging Working Group
17. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease
18. Evaluation and use of diagnostic tests in Alzheimer's disease
19. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
20. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment